Welcome to the No Shock Advised Podcast with Brett and Matt.

This week: We're discussing vasopressors (and inodilators): the what, the where, and the why. There's a lot of ground to cover, so buckle up.

We have a form for asking questions here.

You can check us out on Facebook here.

You can email us @ NoShockAdvisedPodcast@gmail.com.

If you feel led, you can access our Patreon here.

References and Further Readings:

• Ninja Nerd: Vasopressors
• emDOCs: Evidence Based Approach to Pressors in Shock
• Resus: Cardiogenic Shock: Which Vasopressor to Use
• Relias Media: The Use of Vasopressors and Inotropes in the Emergency Department for the Treatment of Shock
• Levy, 2020: Vasopressor Use in Cardiogenic Shock
• Levy, 2019: Inotropes and Vasopressors Use in Cardiogenic Shock: When, Which, and How Much?
• Yue, 2019: Vasopressor Support in Managing Acute Spinal Cord Injury: Current Knowledge
• Ploumis, 2010: A systematic Review of the Evidence Supporting a Role for Vasopressor Support in Acute SCI
• Sedhai, 2022: Vasopressin Versus Norepinephrine as the First-Line Vasopressor in Septic Shock
• Kubena, 2022: Push-Dose Vasopressors in the Emergency Department
• Zotzmann, 2022: Obstructive Shock from Diagnosis to Treatment
• Ammar, 2022: Timing of Vasoactive Agents and Corticosteroid Initiation ins Septic Shock
• Sahoo, 2022: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock